[68Ga]Ga-RPS-309

N/A

Report date: 2025/11/21 17:15:27
NME

Base Information

Drug Name[68Ga]Ga-RPS-309
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[4] 
Mechanisms of ActionFibroblast activation protein alpha inhibitorsPositron-emission tomography enhancers
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNoria Therapeutics IncMolecular Imaging Innovations Institute
China Registration ClassN/A

Develop Information

Active CompaniesMolecular Imaging Innovations InstituteNoria Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A